India to Netherlands: Amlodipine Export Trade Route
India has recorded 221 verified shipments of Amlodipine exported to Netherlands, representing a combined trade value of $25.2M USD. This corridor is served by 28 active Indian exporters, with an average shipment value of $113.8K USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED, which accounts for 91% of total export value with 40 shipments worth $23.0M USD. On the buying side, MYLAN B,V, is the largest importer in Netherlands with $22.4M USD in purchases. The top 3 suppliers — MYLAN LABORATORIES LIMITED, INTAS PHARMACEUTICALS LIMITED, MACLEODS PHARMACEUTICALS LTD — together control 96% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Netherlands Amlodipine corridor is one of India's established pharmaceutical export routes, with 221 shipments documented worth a combined $25.2M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 91% of all export value, reflecting the consolidated nature of India's amlodipine manufacturing sector.
Across 28 active suppliers, the average shipment value stands at $113.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with amlodipine's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 24.5%, placing it at rank #20 among India's top amlodipine export destinations globally.
On the import side, key buyers of Indian amlodipine in Netherlands include MYLAN B,V,, BROCACEF NL HUB, XXCORXXNL XX XXTCH and 85 others. MYLAN B,V, is the single largest importer with 1 shipments valued at $22.4M USD.
